News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Oryzon sede
ORYZON announces formal grant of key European patent for vafidemstat
Healthcare · Innovative drugs · International · EU projects
For the treatment of aggression and social withdrawal. 
Partners - Oryzon Genomics
Ceo Apta Targets
"ApToll is an immune modulator to treat ischaemic stroke in the acute phase. We have successfully completed Phase 2a and will soon conduct Phase 2b. We are also testing ApToll for other indications”
Healthcare · Innovative drugs
David Segarra, an aptamer technology entrepreneur, co-founded aptaTargets in 2014 and has led the…
Partners - GENESIS Biomed
Aprobación ensayo citoquinas Peaches
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
  Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will…
Partners - PEACHES BIOTECH S.L.
Fecundis startup
Fecundis secures $2.4 million in seed funding
Healthcare · Access to innovation · Personalized medicine
This funding will allow the company -based in the Barcelona Science Parkspeed up the path to…
Partners - Parc Científic de Barcelona
CEO de Peaches anunciando aprobación ensayo tormenta citoquinas
AEMPS approves Peaches clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine
Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat…
Partners - PEACHES BIOTECH S.L.
forma pivotal
Fundación Teófilo Hernando, CRO in Spain of a pivotal clinical study with the first medical device designed to restore natural breast shape and sensitivity after partial mastectomy
Healthcare · Access to innovation · Personalized medicine
The international study involves the Complexo Hospitalario Universitario de A Coruña in Spain and…
Partners - Fundación Teófilo Hernando (FTH)
Therapies manufacturing - alira health
Alira Health Releases 2024 Biologics and Advanced Therapies CDMO Market Report Amid Continued Macro-Economic Uncertainty
Healthcare · Drug discovery · Advanced therapies · International
Despite market contraction in 2023, strategic interest in biologics and advanced therapies remains…
hojas de olivo cener
CENER pioneers breakthrough biotechnological solutions for olive leaf valorization
Industrial biotechnology · Bioeconomy
The OLEAF4VALUE project is an ambitious initiative funded by the European Union under the Horizon…
Partners - CENER
Trastorno límite de la personalidad
ORYZON receives minutes from End-of-Phase II meeting with the FDA on the PORTICO-2 Phase III vafidemstat trial in Borderline Personality Disorder
Healthcare · Innovative drugs
Oryzon may use STAXI-2 Trait anger as a primary efficacy endpoint for PORTICO-2.
Partners - Oryzon Genomics